Report Detail

Medical Devices & Consumables Global Microneedle Transdermal Drug Delivery System Market Outlook 2021

  • RnM4268773
  • |
  • 19 December, 2020
  • |
  • Global
  • |
  • 123 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Microneedle Transdermal Drug Delivery System Market Overview

  • 1.1 Product Overview and Scope of Microneedle Transdermal Drug Delivery System
  • 1.2 Microneedle Transdermal Drug Delivery System Segment by Type
    • 1.2.1 Global Microneedle Transdermal Drug Delivery System Production Growth Rate Comparison by Type 2020 VS 2026
    • 1.2.2 Hollow Type
    • 1.2.3 Solid Type
    • 1.2.4 Soluble Type
  • 1.3 Microneedle Transdermal Drug Delivery System Segment by Application
    • 1.3.1 Microneedle Transdermal Drug Delivery System Consumption Comparison by Application: 2020 VS 2026
    • 1.3.2 Drug
    • 1.3.3 Vaccine
  • 1.4 Global Microneedle Transdermal Drug Delivery System Market by Region
    • 1.4.1 Global Microneedle Transdermal Drug Delivery System Market Size Estimates and Forecasts by Region: 2020 VS 2026
    • 1.4.2 North America Estimates and Forecasts (2015-2026)
    • 1.4.3 Europe Estimates and Forecasts (2015-2026)
    • 1.4.4 China Estimates and Forecasts (2015-2026)
    • 1.4.5 Japan Estimates and Forecasts (2015-2026)
  • 1.5 Global Microneedle Transdermal Drug Delivery System Growth Prospects
    • 1.5.1 Global Microneedle Transdermal Drug Delivery System Revenue Estimates and Forecasts (2015-2026)
    • 1.5.2 Global Microneedle Transdermal Drug Delivery System Production Capacity Estimates and Forecasts (2015-2026)
    • 1.5.3 Global Microneedle Transdermal Drug Delivery System Production Estimates and Forecasts (2015-2026)
  • 1.6 Microneedle Transdermal Drug Delivery System Industry
  • 1.7 Microneedle Transdermal Drug Delivery System Market Trends

2 Market Competition by Manufacturers

  • 2.1 Global Microneedle Transdermal Drug Delivery System Production Capacity Market Share by Manufacturers (2015-2020)
  • 2.2 Global Microneedle Transdermal Drug Delivery System Revenue Share by Manufacturers (2015-2020)
  • 2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Microneedle Transdermal Drug Delivery System Average Price by Manufacturers (2015-2020)
  • 2.5 Manufacturers Microneedle Transdermal Drug Delivery System Production Sites, Area Served, Product Types
  • 2.6 Microneedle Transdermal Drug Delivery System Market Competitive Situation and Trends
    • 2.6.1 Microneedle Transdermal Drug Delivery System Market Concentration Rate
    • 2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Microneedle Transdermal Drug Delivery System Market Share by Regions (2015-2020)
  • 3.2 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Regions (2015-2020)
  • 3.3 Global Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.4 North America Microneedle Transdermal Drug Delivery System Production
    • 3.4.1 North America Microneedle Transdermal Drug Delivery System Production Growth Rate (2015-2020)
    • 3.4.2 North America Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.5 Europe Microneedle Transdermal Drug Delivery System Production
    • 3.5.1 Europe Microneedle Transdermal Drug Delivery System Production Growth Rate (2015-2020)
    • 3.5.2 Europe Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.6 China Microneedle Transdermal Drug Delivery System Production
    • 3.6.1 China Microneedle Transdermal Drug Delivery System Production Growth Rate (2015-2020)
    • 3.6.2 China Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.7 Japan Microneedle Transdermal Drug Delivery System Production
    • 3.7.1 Japan Microneedle Transdermal Drug Delivery System Production Growth Rate (2015-2020)
    • 3.7.2 Japan Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Microneedle Transdermal Drug Delivery System Consumption by Regions

  • 4.1 Global Microneedle Transdermal Drug Delivery System Consumption by Regions
    • 4.1.1 Global Microneedle Transdermal Drug Delivery System Consumption by Region
    • 4.1.2 Global Microneedle Transdermal Drug Delivery System Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Microneedle Transdermal Drug Delivery System Consumption by Countries
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Microneedle Transdermal Drug Delivery System Consumption by Countries
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Microneedle Transdermal Drug Delivery System Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Microneedle Transdermal Drug Delivery System Consumption by Countries
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Microneedle Transdermal Drug Delivery System Production, Revenue, Price Trend by Type

  • 5.1 Global Microneedle Transdermal Drug Delivery System Production Market Share by Type (2015-2020)
  • 5.2 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Type (2015-2020)
  • 5.3 Global Microneedle Transdermal Drug Delivery System Price by Type (2015-2020)
  • 5.4 Global Microneedle Transdermal Drug Delivery System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Microneedle Transdermal Drug Delivery System Market Analysis by Application

  • 6.1 Global Microneedle Transdermal Drug Delivery System Consumption Market Share by Application (2015-2020)
  • 6.2 Global Microneedle Transdermal Drug Delivery System Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Microneedle Transdermal Drug Delivery System Business

  • 7.1 3 M
    • 7.1.1 3 M Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.1.2 3 M Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.1.3 3 M Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.1.4 3 M Main Business and Markets Served
  • 7.2 Zosano Pharma
    • 7.2.1 Zosano Pharma Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.2.2 Zosano Pharma Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.2.3 Zosano Pharma Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.2.4 Zosano Pharma Main Business and Markets Served
  • 7.3 Becton-Dickinson(BD)Technologies
    • 7.3.1 Becton-Dickinson(BD)Technologies Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.3.2 Becton-Dickinson(BD)Technologies Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.3.3 Becton-Dickinson(BD)Technologies Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.3.4 Becton-Dickinson(BD)Technologies Main Business and Markets Served
  • 7.4 Nanopass Technologies
    • 7.4.1 Nanopass Technologies Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.4.2 Nanopass Technologies Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.4.3 Nanopass Technologies Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.4.4 Nanopass Technologies Main Business and Markets Served
  • 7.5 Corium
    • 7.5.1 Corium Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.5.2 Corium Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.5.3 Corium Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.5.4 Corium Main Business and Markets Served
  • 7.6 Valeritas
    • 7.6.1 Valeritas Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.6.2 Valeritas Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.6.3 Valeritas Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.6.4 Valeritas Main Business and Markets Served
  • 7.7 Nitto
    • 7.7.1 Nitto Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.7.2 Nitto Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.7.3 Nitto Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.7.4 Nitto Main Business and Markets Served
  • 7.8 Microdermics
    • 7.8.1 Microdermics Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.8.2 Microdermics Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.8.3 Microdermics Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.8.4 Microdermics Main Business and Markets Served
  • 7.9 TheraJect, Inc
    • 7.9.1 TheraJect, Inc Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.9.2 TheraJect, Inc Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.9.3 TheraJect, Inc Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.9.4 TheraJect, Inc Main Business and Markets Served
  • 7.10 Vaxxas
    • 7.10.1 Vaxxas Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.10.2 Vaxxas Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.10.3 Vaxxas Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.10.4 Vaxxas Main Business and Markets Served
  • 7.11 Lohmann Therapie-Systeme AG
    • 7.11.1 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Production Sites and Area Served
    • 7.11.2 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Product Introduction, Application and Specification
    • 7.11.3 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.11.4 Lohmann Therapie-Systeme AG Main Business and Markets Served

8 Microneedle Transdermal Drug Delivery System Manufacturing Cost Analysis

  • 8.1 Microneedle Transdermal Drug Delivery System Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Microneedle Transdermal Drug Delivery System
  • 8.4 Microneedle Transdermal Drug Delivery System Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Microneedle Transdermal Drug Delivery System Distributors List
  • 9.3 Microneedle Transdermal Drug Delivery System Customers

10 Market Dynamics

  • 10.1 Market Trends
  • 10.2 Opportunities and Drivers
  • 10.3 Challenges
  • 10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Microneedle Transdermal Drug Delivery System (2021-2026)
  • 11.2 Global Forecasted Revenue of Microneedle Transdermal Drug Delivery System (2021-2026)
  • 11.3 Global Forecasted Price of Microneedle Transdermal Drug Delivery System (2021-2026)
  • 11.4 Global Microneedle Transdermal Drug Delivery System Production Forecast by Regions (2021-2026)
    • 11.4.1 North America Microneedle Transdermal Drug Delivery System Production, Revenue Forecast (2021-2026)
    • 11.4.2 Europe Microneedle Transdermal Drug Delivery System Production, Revenue Forecast (2021-2026)
    • 11.4.3 China Microneedle Transdermal Drug Delivery System Production, Revenue Forecast (2021-2026)
    • 11.4.4 Japan Microneedle Transdermal Drug Delivery System Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted and Consumption Demand Analysis of Microneedle Transdermal Drug Delivery System
  • 12.2 North America Forecasted Consumption of Microneedle Transdermal Drug Delivery System by Country
  • 12.3 Europe Market Forecasted Consumption of Microneedle Transdermal Drug Delivery System by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Microneedle Transdermal Drug Delivery System by Regions
  • 12.5 Latin America Forecasted Consumption of Microneedle Transdermal Drug Delivery System

13 Forecast by Type and by Application (2021-2026)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
    • 13.1.1 Global Forecasted Production of Microneedle Transdermal Drug Delivery System by Type (2021-2026)
    • 13.1.2 Global Forecasted Revenue of Microneedle Transdermal Drug Delivery System by Type (2021-2026)
    • 13.1.3 Global Forecasted Price of Microneedle Transdermal Drug Delivery System by Type (2021-2026)
  • 13.2 Global Forecasted Consumption of Microneedle Transdermal Drug Delivery System by Application (2021-2026)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Hollow Type
    Solid Type
    Soluble Type

    Segment by Application
    Drug
    Vaccine

    Global Microneedle Transdermal Drug Delivery System Market: Regional Analysis
    The report offers in-depth assessment of the growth and other aspects of the Microneedle Transdermal Drug Delivery System market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
    The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

    Global Microneedle Transdermal Drug Delivery System Market: Competitive Landscape
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
    The major players in the market include 3 M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Inc, Vaxxas, Lohmann Therapie-Systeme AG, etc.


    Summary:
    Get latest Market Research Reports on Microneedle Transdermal Drug Delivery System. Industry analysis & Market Report on Microneedle Transdermal Drug Delivery System is a syndicated market report, published as Global Microneedle Transdermal Drug Delivery System Market Outlook 2021. It is complete Research Study and Industry Analysis of Microneedle Transdermal Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,133.33
    3,200.00
    4,266.67
    2,395.37
    3,593.06
    4,790.75
    300,970.70
    451,456.05
    601,941.40
    212,316.54
    318,474.81
    424,633.08
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report